INSTITUT PASTEUR
Patent Owner
Stats
- 450 US PATENTS IN FORCE
- 24 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 450 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 9,538 Total Citation Count
- Sep 29, 1975 Earliest Filing
- 656 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0008,723 MULTIMERIC COMPOUNDS OF A KRINGLE DOMAIN FROM THE HEPATOCYTE GROWTH FACTOR / SCATTER FACTOR (HGF/SF)Jan 21, 16Jan 11, 18[A61K, G01N]
2017/0369,888 ADAM12 Inhibitors and Their Use Against Inflammation-Induced FibrosisAug 29, 17Dec 28, 17[A61K, C12Q, C12N, G01N, A01K]
2017/0362,607 USE OF NON-SUBTYPE B GAG PROTEINS FOR LENTIVIRAL PACKAGINGAug 10, 17Dec 21, 17[C12N, C07K]
2017/0354,709 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEDec 23, 15Dec 14, 17[A61K]
2017/0334,975 POLYCLONAL ANTIBODIES SPECIFIC FOR SEROGROUP X OF N. MENINGITIDIS AND USES THEREOF IN DIAGNOSISNov 17, 15Nov 23, 17[G01N, C07K]
2017/0326,246 CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO AN ANIONIC POLYPEPTIDE FOR THE TREATMENT OF AIDSOct 23, 15Nov 16, 17[A61K, C07K]
2017/0327,572 TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY ANTAGONISM OF THE IL-20RNov 23, 15Nov 16, 17[A61K, C07K]
2017/0238,556 INSECTICIDE PROPERTIES OF AN EXTRACT OF SEXTONIA RUBRA, AND THE CONSTITUENTS THEREOFSep 22, 15Aug 24, 17[A01N]
2017/0212,113 PREDICTIVE VALUE OF CLOSTRIDIUM DIFFICILE-SPECIFIC IMMUNE RESPONSE FOR RECURRENCE AND DISEASE OUTCOMEApr 01, 15Jul 27, 17[A61K, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9919029 Methods and pharmaceutical compositions for the treatment of bacterial infectionsJul 25, 14Mar 20, 18[A61K]
9913829 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compoundJul 29, 11Mar 13, 18[A61K]
9914937 Recombinant measles viruses expressing epitopes of antigens of RNA viruses—use for the preparation of vaccine compositionsMar 24, 15Mar 13, 18[A61K, C12N, C07K]
9907860 Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDSOct 23, 15Mar 06, 18[A61K, C07K]
9894888 Transgenic immunodeficient mouse expressing human SIRP-alphaMar 26, 13Feb 20, 18[C12N, A01K, G01N, C07K]
9889193 Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-deltaC virus) in cancer therapyJan 20, 14Feb 13, 18[A61K, C12N]
9868989 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detectionSep 18, 15Jan 16, 18[C12Q]
9839683 Vaccine for prophylaxis or treatment of an allergen-driven airway pathologyJan 30, 15Dec 12, 17[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0182,077 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedFeb 13, 15Jun 29, 17[A61K, C07K]
2016/0217,250 IDENTIFYING MOLECULAR SYSTEMS IN PROTEIN SEQUENCE DATAAbandonedJan 27, 15Jul 28, 16[G06F, C40B]
2016/0166,646 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedJun 27, 14Jun 16, 16[A61K]
2016/0047,810 METHODS TO OBTAIN A NOVEL CLASS OF GRAM NEGATIVE BACTERIA ANTIBIOTICS WHICH TARGET AN UNKNOWN CELL DIVISION ASSOCIATED PROTEIN LOP1AbandonedApr 08, 14Feb 18, 16[C12Q, C12N, G01N, C07K]
2015/0343,018 NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLSAbandonedOct 03, 13Dec 03, 15[A61K, G01N]
2015/0246,095 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZAAbandonedOct 01, 13Sep 03, 15[A61K, C12Q, G01N]
2015/0224,129 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA WITH INVARIANT NKT CELL AGONISTSAbandonedOct 01, 13Aug 13, 15[A61K]
2015/0168,399 MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECTAbandonedFeb 13, 15Jun 18, 15[G01N]
2015/0071,873 Cancer Treatment by Immunotherapy With BCG or Antigenically Related Non-Pathogenic MycobacteriaAbandonedJan 24, 13Mar 12, 15[A61K, G01N]
2014/0336,126 OPTINEURIN-DERIVED POLYPEPTIDES, THEIR NUCLEIC ACIDS AND USES THEREOFAbandonedDec 18, 12Nov 13, 14[G01N, C07K]
2014/0294,791 Lactobacillus paracasei subsp. paracasei, as an agent for inhibiting listeria monocytogenes in vivo infectionAbandonedDec 01, 11Oct 02, 14[A61K, A23L]
2014/0206,081 VARIABLE DOMAINS OF CAMELID HEAVY-CHAIN ANTIBODIES DIRECTED AGAINST GLIAL FIBRILLARY ACIDIC PROTEINSAbandonedMay 08, 13Jul 24, 14[C12N]
2014/0193,843 USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKERAbandonedFeb 14, 14Jul 10, 14[G01N]
2014/0154,289 ATTENUATED PLASMODIUM WITH DEACTIVATED HMGB2 GENE, AS VACCINEAbandonedJul 19, 12Jun 05, 14[A61K]
2014/0088,184 Use of Epigallocatechin Gallate as an Antiviral Agent against infections by the Hepatitis C VirusAbandonedMar 28, 12Mar 27, 14[A61K]
8563008 Polynucleotides and polypeptides involved in gestational malaria, and biological applicationsExpiredApr 17, 08Oct 22, 13[A61K, C07H, C07K]
8551500 Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune responseExpiredMay 08, 08Oct 08, 13[A61K]
8541206 Differential amplification of mutant nucleic acids by PCR in a mixture of nucleic acidsExpiredDec 28, 06Sep 24, 13[C12P]
8481486 Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-RExpiredSep 15, 08Jul 09, 13[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.